Eptifibatidă Rompharm

Eptifibatide is an intravenous medication used to prevent blood clots. It works by inhibiting platelet aggregation, often used in cardiac procedures.

Eptifibatide is primarily used to prevent blood clots in patients undergoing certain heart procedures. It is often administered intravenously to reduce the risk of clotting during cardiac interventions. This medication is commonly used in settings where preventing platelet aggregation is crucial for patient safety.

Eptifibatide works by inhibiting the aggregation of platelets, which helps to prevent the formation of blood clots. Common effects may include a reduced risk of clotting during cardiac procedures. Patients may experience minor side effects, but these can vary widely.

Eptifibatide should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to follow medical guidance when administering this medication to avoid potential complications. Always consult a healthcare provider before use.

Eptifibatide may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eptifibatide.